Novel psoriasis therapies and patient outcomes, part 1: topical medications.
about
Evidence of Bioactive Compounds from Vernonia polyanthes Leaves with Topical Anti-Inflammatory PotentialUpdates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by.Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model
P2860
Novel psoriasis therapies and patient outcomes, part 1: topical medications.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Novel psoriasis therapies and patient outcomes, part 1: topical medications.
@en
type
label
Novel psoriasis therapies and patient outcomes, part 1: topical medications.
@en
prefLabel
Novel psoriasis therapies and patient outcomes, part 1: topical medications.
@en
P2093
P1433
P1476
Novel psoriasis therapies and patient outcomes, part 1: topical medications.
@en
P2093
Barry L Smith
Jeffrey M Weinberg
Meghan A Feely
P304
164-8, 170
P577
2015-03-01T00:00:00Z